Trial Profile
A Phase II, Randomized, Open-Label, Dose-Ranging Study of Intravenous Artesunate Therapy for the Treatment of Acute, Uncomplicated Plasmodium Falciparum Malaria.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jul 2019
Price :
$35
*
At a glance
- Drugs Artesunate (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- 18 Nov 2014 New trial record